The toolkit provides information on how an AIDS vaccine works, and why it is so challenging to develop one. Basic principles of research and development are included, as well as the current status of the global AIDS vaccine research effort. The toolkit presents the latest figures on funding of AIDS vaccine research, and ends with information on IAVI.

Originally aired as part of BBC World's "Kill or Cure?" series, this 4-minute documentary features AIDS specialists, researchers, and community workers discussing the impact of HIV/AIDS on their communities and their efforts to find a solution to the epidemic.
International AIDS Vaccine Initiative (IAVI) partners at the Kenya AIDS Vaccine Initiative and the Tuberculosis Research Centre in India, as well as IAVI President Seth Berkley, discuss the critical need for a sustained global effort to develop an AIDS vaccine.

Leading researchers from IAVI, CDC and the USMHRP presented final results from a collection of independent studies reexamining the medical criteria for including African volunteers in AIDS vaccine trials.

New class of viral vector tapped to target primary site of HIV replication; Agreement marks IAVI’s first product development partnership with Japanese company.

The International AIDS Vaccine Initiative (IAVI) and its worldwide partners mark May 18 as World AIDS Vaccine Day to promote the continued urgent need for a vaccine to prevent HIV infection and AIDS. We also acknowledge the vital contributions of approximately 20,000 volunteers enrolled in AIDS vaccine trials around the world today who have selflessly committed to advancing research.

Please see below to read the publication from the Global Coalition on Women and AIDS which discusses HIV prevention options for women and the promising new developments in the field. The publication also highlights actions that need to be taken by national and local governments to make sure these prevention options are available to all women.

Twenty-five years after the discovery of a novel immunodeficiency disease, later to become known as AIDS, an estimated 39.5 million people worldwide are living with HIV, many of whom will die from AIDS-related complications in the coming decades. Halting the epidemic is a prerequisite for reaching the key social and economic Millennium Development Goals (MDGs) to reduce poverty rates and child mortality, ensure that all children complete primary education and improve maternal health

Out of an estimated 39.5 million people living with HIV worldwide at the end 2006, 4.3 million were newly infected last year alone, according to the latest statistics released by the Joint United Nations Program on HIV/AIDS (UNAIDS) and the World Health Organization in advance of World AIDS Day. Twenty-five years after scientists reported the first cases of a novel immunodeficiency disease, later to become known as AIDS, the pandemic shows no signs of abating. HIV/AIDS is among the most serious threats to long-term global development and stability today, undermining efforts to improve living standards worldwide.